{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:01:43Z","timestamp":1765742503543,"version":"3.48.0"},"reference-count":31,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,28]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a globally prevalent endocrinological disorder and has been associated with poor pregnancy outcomes, including a higher rate of gestational diabetes and miscarriage. Metformin is among the drugs investigated to improve the prognosis of pregnant women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To conduct an overview of systematic reviews examining the effects of metformin versus placebo or no intervention throughout pregnancy among pregnant women with a preconception PCOS diagnosis to reduce the incidence of miscarriage and gestational diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will perform an overview of systematic reviews by searching Embase, PubMed, Virtual Health Library, Cochrane Central Register of Controlled Trials, Trip Database, Scopus, Web of Science and Cumulative Index to Nursing and Allied Health Literature from inception to 17 August 2023. Language, publication status and year indexed or published filters will not be applied. Two reviewers will independently screen and select papers, assess their quality, evaluate their risk of bias and collect the data. The included reviews will be summarised narratively. The quality and risk of bias of the systematic review and meta-analysis studies included will be assessed using AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews, Second Version) and ROBIS (Risk of Bias in Systematic Reviews), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This overview of reviews will analyse data from systematic reviews on the use of metformin for prepregnancy diagnosis of PCOS to reduce adverse outcomes. As there will be no primary data collection, a formal ethical analysis is unnecessary. The study outcomes will be submitted to a peer-reviewed journal and presented at conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023441488.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-078217","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:15:18Z","timestamp":1711412118000},"page":"e078217","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of metformin to pregnant women with PCOS to reduce spontaneous abortion and gestational diabetes mellitus: a protocol for an overview of reviews"],"prefix":"10.1136","volume":"14","author":[{"given":"Darmaris Souza","family":"Nassif","sequence":"first","affiliation":[{"name":"Botucau Medical School - Department of Obstetrics and Gynecology, S\u00e3o Paulo State University - UNESP, Botucatu, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca L\u00facia","family":"Janu\u00e1rio","sequence":"additional","affiliation":[{"name":"Botucau Medical School, UNESP, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Antunes","family":"Sousa","sequence":"additional","affiliation":[{"name":"Botucau Medical School, UNESP, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-9734","authenticated-orcid":false,"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Biostatistics Unit, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-1451","authenticated-orcid":false,"given":"Joelcio Francisco","family":"Abbade","sequence":"additional","affiliation":[{"name":"Botucau Medical School - Department of Obstetrics and Gynecology, S\u00e3o Paulo State University - UNESP, Botucatu, S\u00e3o Paulo, Brazil"},{"name":"Maternal Fetal Medicine Department, Hospital das Cl\u00ednicas da Faculdade de Medicina de Botucatu, Botucatu, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"2025121223123424000_14.3.e078217.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2025121223123424000_14.3.e078217.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.4006"},{"key":"2025121223123424000_14.3.e078217.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.9.3078"},{"key":"2025121223123424000_14.3.e078217.4","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clinical Endocrino & Metaboli"},{"key":"2025121223123424000_14.3.e078217.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"},{"key":"2025121223123424000_14.3.e078217.6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399"},{"key":"2025121223123424000_14.3.e078217.7","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh011"},{"key":"2025121223123424000_14.3.e078217.8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12008"},{"key":"2025121223123424000_14.3.e078217.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1045"},{"key":"2025121223123424000_14.3.e078217.10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei221"},{"key":"2025121223123424000_14.3.e078217.11","doi-asserted-by":"publisher","DOI":"10.1111\/OBR.12829"},{"key":"2025121223123424000_14.3.e078217.12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025121223123424000_14.3.e078217.13","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml036"},{"key":"2025121223123424000_14.3.e078217.14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2025121223123424000_14.3.e078217.15","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-56"},{"key":"2025121223123424000_14.3.e078217.16","doi-asserted-by":"crossref","first-page":"182582","DOI":"10.1155\/2013\/182582","article-title":"Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome","volume":"2013","author":"Wang","year":"2013","journal-title":"Biomed Res Int"},{"key":"2025121223123424000_14.3.e078217.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.087"},{"key":"2025121223123424000_14.3.e078217.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1126"},{"key":"2025121223123424000_14.3.e078217.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.04.021"},{"key":"2025121223123424000_14.3.e078217.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.2.569"},{"key":"2025121223123424000_14.3.e078217.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.05.035"},{"key":"2025121223123424000_14.3.e078217.22","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1034"},{"key":"2025121223123424000_14.3.e078217.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0965"},{"key":"2025121223123424000_14.3.e078217.24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/09513590.2022.2080194","article-title":"Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials","volume":"38","author":"Zhao","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"2025121223123424000_14.3.e078217.25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2022.01.025","article-title":"Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? meta-analysis and systematic review","volume":"271","author":"Magzoub","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025121223123424000_14.3.e078217.26","unstructured":"Pollock M , Fernandes RM , Becker LA , et al . Chapter V: overviews of reviews. In: Higgins J , Thomas J , Chandler J , eds. Cochrane Handbook for Systematic Reviews of Interventions version 63. Cochrane, 2022. Available: https:\/\/training.cochrane.org\/handbook\/current\/chapter-v"},{"key":"2025121223123424000_14.3.e078217.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ"},{"key":"2025121223123424000_14.3.e078217.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of Healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"2025121223123424000_14.3.e078217.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005"},{"key":"2025121223123424000_14.3.e078217.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025121223123424000_14.3.e078217.31","unstructured":"McMaster University and Evidence Prime . Gradepro GDT: Gradepro guideline development tool [Internet]. 2022. Available: https:\/\/www.gradepro.org\/"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-078217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:12:44Z","timestamp":1765609964000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-078217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,25]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-078217"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-078217","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}